Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
46.52 EUR | +3.68% | +7.15% | -4.54% |
04-24 | COVIVIO : Invest Securities remains Buy after sales release | CF |
04-24 | Covivio: stable revenues in Q1 | CF |
Sales 2024 * | 1.08B 1.15B 92.11B | Sales 2025 * | 1.09B 1.17B 93.41B | Capitalization | 4.67B 4.99B 400B |
---|---|---|---|---|---|
Net income 2024 * | 118M 126M 10.1B | Net income 2025 * | 499M 534M 42.73B | EV / Sales 2024 * | 10.3 x |
Net Debt 2024 * | 6.44B 6.89B 552B | Net Debt 2025 * | 6.31B 6.75B 541B | EV / Sales 2025 * | 10.1 x |
P/E ratio 2024 * |
47
x | P/E ratio 2025 * |
9.34
x | Employees | - |
Yield 2024 * |
7.32% | Yield 2025 * |
7.38% | Free-Float | 67.78% |
Latest transcript on Covivio
1 day | +3.68% | ||
1 week | +7.15% | ||
Current month | +0.04% | ||
1 month | +1.79% | ||
3 months | +2.01% | ||
6 months | +24.38% | ||
Current year | -4.54% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 58 | 30/09/01 | |
Paul Arkwright
DFI | Director of Finance/CFO | 38 | 31/12/13 |
Chief Tech/Sci/R&D Officer | 36 | 14/02/18 |
Members of the board | Title | Age | Since |
---|---|---|---|
Olivier Piani
BRD | Director/Board Member | 70 | 16/04/19 |
Jérôme Grivet
BRD | Director/Board Member | 62 | 30/01/11 |
Chief Executive Officer | 58 | 30/09/01 |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 46.66 | +4.30% | 55,078 |
25/04/24 | 44.73 | -0.08% | 62,057 |
24/04/24 | 44.77 | +0.02% | 66,236 |
23/04/24 | 44.76 | +0.86% | 151,496 |
22/04/24 | 44.38 | +2.21% | 149,425 |
Delayed Quote London S.E., April 26, 2024 at 04:30 pm
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-6.46% | 46.25B | |
-8.31% | 20.33B | |
-3.56% | 13.07B | |
+16.05% | 11.53B | |
-4.85% | 9.68B | |
-0.83% | 8.48B | |
-14.19% | 8.38B | |
+1.38% | 7.63B | |
-18.42% | 5.53B |
- Stock Market
- Equities
- COV Stock
- 0J6V Stock